Browse Studies — Arctuva

Phase 2

Phase II Study Assessing the Effect of BK Specific CTL Lines Generated by Ex Vivo Expansion in Patients With BK Virus Infection and JC Virus Infection

This phase II trial studies how well donor cytotoxic T lymphocytes work in treating patients with malignancies with BK and/or JC virus. Cytotoxic T lymphocytes…

Acquired Immunodeficiency SyndromeBK Virus InfectionHuman Immunodeficiency Virus+5 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT02479698

Immune Registry for BK (Polyomavirus Hominis 1) in Kidney Transplant Recipients

Kidney transplantation (KT) is the best treatment modality available to date for patients with advanced kidney disease and the success of KT is dependent on ma…

BK Virus InfectionKidney Transplant; Complications

Estimated

~$10 – $750

Virginia Commonwealth UniversityNCT06538961

Phase 1

Single Center Phase I Study of Adoptive Immunotherapy of Refractory Viral Infection With ex Vivo Expanded Rapidly Generated Virus Specific T (R-MVST) Cells for Immunodeficient Children and Young Adults

The primary objective is to determine the safety and feasibility of administering R-MVST cells to patients with refractory viral reactivation and/or symptomati…

Epstein-Barr VirusCytomegalovirus InfectionsAdenovirus+2 more

Estimated

~$10 – $7,500

Monica BhatiaNCT06926894

Phase 1

Phase I Study of Adoptive Immunotherapy of Refractory Viral Infection With ex Vivo Expanded Rapidly Generated Virus Specific T (R-MVST) Cells

The primary objective is to determine the safety and feasibility of administering R-MVST cells to patients with refractory viral reactivation and/or symptomati…

Epstein-Barr Virus InfectionsCytomegalovirus InfectionsAdenovirus+1 more

Estimated

~$10 – $6,250

Columbia UniversityNCT05183490